As at 10:57 AM on 8/9/2010
The Share Price is: 27.50 GBX
Home > News
As you’d expect from a company in emerging technologies and world class IP, our companies generate considerable news. Full details of all RNS and portfolio company related announcements are detailed below:
Plan Ahead launches fertility test in US
11 Jan 2008
i2L signs strategic alliance with Agri2000 Soc. Coop
19 Dec 2007
AGM statement
30 Nov 2007
Celltran products enter two new Phase I trials
15 Nov 2007
Biofusion Preliminary Results to 31 July 2007
15 Oct 2007
Lifestyle Choices signs US licence agreement
11 Oct 2007
Trade sale of Cardiff ProTides and Cardiff Biologicals to Morvus
10 Oct 2007
Biofusion raises shareholding in Cardiff Biologicals to 50%
02 Oct 2007
Biofusion increases shareholding in Cardiff Protides to 50%
Biofusion signs MOU with Finance Wales and increases stake in Abcellute
21 Sep 2007